A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years

BACKGROUND: A previous phase 2 study demonstrated the immunogenicity of a single dose of meningococcal A, C, W, Y-tetanus toxoid conjugate (MenACWY-TT) or polysaccharide (MenACWY-PS) vaccine for up to 5 years in individuals aged 11–55 years. This follow-up study evaluated long-term antibody persiste...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Infect Dis
Главные авторы: Borja-Tabora, Charissa Fay Corazon, Peyrani, Paula, Webber, Chris, Van der Wielen, Marie, Cheuvart, Brigitte, De Schrevel, Nathalie, Bianco, Veronique, Aris, Emmanuel, Cutler, Mark, Li, Ping, Perez, John L.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2020
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7301505/
https://ncbi.nlm.nih.gov/pubmed/32552685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-05104-5
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы